QIAGEN N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.26 USD | +1.45% |
|
-1.07% | -3.38% |
| May. 31 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
| May. 31 | Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 46.67 | 46.67 | 48.58 |
| Spread/Res. | -7.31% | -7.31% | -10.95% |
| Spread/Supp. | +5.31% | +10.27% | +16.21% |
| Support | 41.08 | 39.23 | 37.23 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- QGEN Stock
- Charts Qiagen N.V.
